Related Experiment Video
Updated: Jun 5, 2025
10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
18.9K
Mapping Disciplinary Competencies and Learning Outcomes to the Competency-Based Veterinary Education Framework Using
Martin Hawes1, Virginia Fajt2, Arno H Werners3
1Department of Comparative Biomedical Sciences, School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom.
Journal of Veterinary Medical Education
|December 9, 2024
Summary
The competency-based veterinary education (CBVE) framework needs to better integrate pharmacology competencies. This study identified gaps in current veterinary pharmacology competencies, highlighting the need for updates to ensure safe and effective drug use.
Area of Science:
- Veterinary Education
- Pharmacology
Background:
- The competency-based veterinary education (CBVE) framework outlines essential graduate competencies.
- Integrating basic and clinical science knowledge, particularly pharmacology, into teaching remains a challenge.
Purpose of the Study:
- To identify and address the lack of specific drug selection and use competencies within the CBVE framework.
- To guide veterinary pharmacology educators by mapping existing competencies.
Main Methods:
- Identified CBVE competencies relevant to veterinary pharmacology.
- Mapped the 2021 Day One competencies in veterinary pharmacology to the CBVE framework.
Main Results:
- Gaps, redundancies, and a lack of clinical practice integration were found in the Day One veterinary pharmacology competencies.
- Ambiguities and gaps were also identified within the CBVE framework itself.
Conclusions:
- Further research is required to update veterinary pharmacology competencies.
- Alignment of pharmacology concepts with the CBVE framework and clear progression milestones for safe prescribing are necessary.
Keywords:
competenciescompetency-based educationcurriculum mappingpharmacologytreatment planningveterinary educationMore Related Videos
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
01:21Pharmacodynamics: Overview and Principles
958
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
958
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
75
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
75
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
01:20Pharmacokinetic Models: Overview
582
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
582